Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04500756 · ClinicalTrials.gov registry record · Phase 2
Limiting AAA With Metformin (LIMIT) Trial
A Phase 2 study of Abdominal Aortic Aneurysm, sponsored by Stanford University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 314
- Enrollment target
- 1
- Study location
NCT04500756 is a Phase 2 study of Abdominal Aortic Aneurysm that is actively recruiting participants, run by Stanford University. The registered enrollment target is 314 participants, below the 434-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04500756, a Phase 2 study of Abdominal Aortic Aneurysm, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 314 participants
- Enrollment target
- 1
- Study location
Study Summary
In this research, the investigators are looking at the effects of a drug called metformin may have on the growth of abdominal aortic aneurysm (AAA)s. AAA is an abnormal enlargement of the aorta, which is the large artery in the abdomen (stomach area). The enlargement of the aorta carries a risk that it will rupture and cause life-threatening bleeding in the abdomen (belly). In this study the investigators hope to learn how metformin is associated with the enlargement or change in size of the AAA in study participants. Smaller studies have suggested that metformin may reduce the rate at which aortic aneurysms enlarge. This study will test this question: does metformin prevent AAAs from growing larger?
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Metformin
Study Locations (1)
California
- Stanford Hospital and Clinics - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 314 participants |
| Start Date | 2022-02-28 |
| Est. Completion | 2028-06-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04500756
The ClinicalTrials.gov registry entry for NCT04500756 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 314 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 434-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (28% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04500756 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04500756 about?
NCT04500756 is a clinical study titled "Limiting AAA With Metformin (LIMIT) Trial". In this research, the investigators are looking at the effects of a drug called metformin may have on the growth of abdominal aortic aneurysm (AAA)s. AAA is an abnormal enlargement of the aorta, which is the large artery in the abdomen (stomach area). The enlargement of the aorta carries a risk that...
What is the current status of trial NCT04500756?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 314 participants. The study started on 2022-02-28. Estimated completion is 2028-06-30.
What conditions does trial NCT04500756 study?
This clinical trial studies the following conditions: Abdominal Aortic Aneurysm.
What interventions are being tested in trial NCT04500756?
The interventions under investigation include: Placebo (OTHER), Metformin (DRUG).
Who is sponsoring clinical trial NCT04500756?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04500756 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nectero EAST System Clinical Study
RECRUITING · Phase 2
-
Terumo Aortic Global Endovascular Registry
RECRUITING
-
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
RECRUITING · NA
-
PET Imaging of MMP Activation in AAA: Clinical Component
RECRUITING · Early Phase 1
-
The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System
RECRUITING
-
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.